Listeria-based booster improves vaccine’s protection against recurring colon cancer
New research in mice has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.
Materials provided by Thomas Jefferson University. Note: Content may be edited for style and length.
Source link aaaaa